PMID- 2836561 OWN - NLM STAT- MEDLINE DCOM- 19880628 LR - 20190630 IS - 0022-3042 (Print) IS - 0022-3042 (Linking) VI - 50 IP - 6 DP - 1988 Jun TI - GABAA receptor populations bind agonists and antagonists differentially and with opposite affinities. PG - 1865-71 AB - Pretreatment of synaptosomal membranes with a diazo-coupling reagent and the presence of Cl- ions were used to differentiate high- and low-affinity populations of postsynaptic gamma-aminobutyric acid (GABAA) receptors. The super-low-affinity GABAA receptors were characterized by the enhancing effect of GABA on [3H]diazepam binding. The GABA antagonists 2-(3-carboxypropyl)-3-amino-4-methyl-6-phenylpyridazinium chloride (SR 95103) and 3-alpha-hydroxy-16-imino-5 beta-17-aza-androstan-11-one (R 5135) shifted and suppressed the dose-response curve of GABA on diazepam binding. SR 95103 displaced the lower affinity [3H]GABA binding with higher potency. Dissociation of the binding of the antagonist 2-(3-carboxypropyl)-3-amino-6-p-methoxyphenylpyridazinium bromide ([3H]SR 95531) was polyphasic. Displacing potencies of SR 95531 and GABA were examined on the major (85%) rapid and minor slower phases of dissociation separated kinetically. The slower phase corresponded to higher affinity binding of SR 95531 which was displaced by GABA with about 10 times less potency. Photoaffinity labeling with muscimol decreased the number of [3H]muscimol binding sites by 27%. It decreased the displacing potency of GABA by 72%, but not that of bicuculline methiodide. These findings can be explained by a preferential binding of antagonists to hydrophobic accessory sites around low-affinity GABAA receptors. FAU - Maksay, G AU - Maksay G AD - Laboratory of Pharmacodynamics, Hungarian Academy of Sciences, Budapest. LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Neurochem JT - Journal of neurochemistry JID - 2985190R RN - 0 (Affinity Labels) RN - 0 (Androstanes) RN - 0 (Azasteroids) RN - 0 (Diazonium Compounds) RN - 0 (GABA Antagonists) RN - 0 (Pyridazines) RN - 0 (Receptors, GABA-A) RN - 0 (Sulfanilic Acids) RN - 2763-96-4 (Muscimol) RN - 56-12-2 (gamma-Aminobutyric Acid) RN - 96440-63-0 (2-(carboxy-3'-propyl)-3-amino-4-methyl-6-phenylpyridazinium chloride) RN - 99460MG420 (gabazine) RN - Q3JTX2Q7TU (Diazepam) RN - R1OGA081AP (RU 5135) RN - Z0105S98AO (diazobenzenesulfonic acid) SB - IM MH - Affinity Labels MH - Androstanes/metabolism MH - Animals MH - Azasteroids/metabolism MH - Brain/*metabolism MH - Diazepam/*metabolism MH - Diazonium Compounds/pharmacology MH - *GABA Antagonists MH - Male MH - Muscimol/metabolism MH - Photochemistry MH - Pyridazines/metabolism MH - Rats MH - Rats, Inbred Strains MH - Receptors, GABA-A/drug effects/*metabolism MH - Sulfanilic Acids/pharmacology MH - Synaptic Membranes/*metabolism MH - gamma-Aminobutyric Acid/metabolism EDAT- 1988/06/01 00:00 MHDA- 1988/06/01 00:01 CRDT- 1988/06/01 00:00 PHST- 1988/06/01 00:00 [pubmed] PHST- 1988/06/01 00:01 [medline] PHST- 1988/06/01 00:00 [entrez] AID - 10.1111/j.1471-4159.1988.tb02490.x [doi] PST - ppublish SO - J Neurochem. 1988 Jun;50(6):1865-71. doi: 10.1111/j.1471-4159.1988.tb02490.x.